Giorgio Milazzo

3.3k total citations · 1 hit paper
20 papers, 2.2k citations indexed

About

Giorgio Milazzo is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Giorgio Milazzo has authored 20 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Giorgio Milazzo's work include Neuroblastoma Research and Treatments (14 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Protein Degradation and Inhibitors (4 papers). Giorgio Milazzo is often cited by papers focused on Neuroblastoma Research and Treatments (14 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Protein Degradation and Inhibitors (4 papers). Giorgio Milazzo collaborates with scholars based in Italy, Australia and United States. Giorgio Milazzo's co-authors include Raymond J. Turner, Stefano Fedi, Martina Cappelletti, Davide Zannoni, Alessandro Presentato, Dario Frascari, Giovanni Perini, Federico M. Giorgi, Daniele Mercatelli and Luca Triboli and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Giorgio Milazzo

20 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genes

2015 1.6k citations Martina Cappelletti, Alessandro Presentato et al. Frontiers in Microbiology profile →

Peers

Countries citing papers authored by Giorgio Milazzo

Since Specialization

Citations

This map shows the geographic impact of Giorgio Milazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Milazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Milazzo more than expected).

Fields of papers citing papers by Giorgio Milazzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Milazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Milazzo. The network helps show where Giorgio Milazzo may publish in the future.

Co-authorship network of co-authors of Giorgio Milazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Milazzo. A scholar is included among the top collaborators of Giorgio Milazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Milazzo. Giorgio Milazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Marco Russo, (unknown), (unknown), Giovanni Capranico, Giorgio Milazzo, Giovanni Perini	1
2	MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma 2022 ·Nature Communications ·Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, Myrthala Moreno‐Smith, (unknown), Barry Zorman, Andrew Badachhape, (unknown), (unknown), Zihua Zeng, Jennifer H. Foster, (unknown), Pavel Sumazin, Youli Zu, John Hicks, Ketan B. Ghaghada, Nagireddy Putluri, Giovanni Perini, Cristian Coarfa, Eveline Barbieri	38
3	Contribution of CACNA1H Variants in Autism Spectrum Disorder Susceptibility 2022 ·Frontiers in Psychiatry ·(unknown), (unknown), (unknown), Annio Posar, Paola Visconti, Maria Cristina Scaduto, (unknown), Magali Jane Rochat, Fabiola Ceroni, Giorgio Milazzo, Sergio Fucile, Elena Maestrini, Elena Bacchelli	9
4	Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma Cells 2022 ·Genes ·Giorgio Milazzo, Giovanni Perini, Federico M. Giorgi	6
5	Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs 2021 ·International Journal of Molecular Sciences ·Roberto Ciaccio, (unknown), (unknown), (unknown), (unknown), (unknown), Giovanni Perini, Giorgio Milazzo	13
6	Restoration of the molecular clock is tumor suppressive in neuroblastoma 2021 ·Nature Communications ·Myrthala Moreno‐Smith, Giorgio Milazzo, Ling Tao, Baharan Fekry, Bokai Zhu, Mahmoud A. Mohammad, Simone Di Giacomo, Roshan M. Borkar, (unknown), Mario Capasso, Sanjeev A. Vasudevan, Pavel Sumazin, John Hicks, Nagireddy Putluri, Giovanni Perini, Kristin Eckel‐Mahan, Thomas P. Burris, Eveline Barbieri	32
7	Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability 2020 ·Genes ·Giorgio Milazzo, Daniele Mercatelli, (unknown), Luca Triboli, (unknown), Giovanni Perini, Federico M. Giorgi	252
8	MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma 2018 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Pier Francesco Ferrucci, Roberto Ciaccio, (unknown), (unknown), Simone Di Giacomo, Stefania Purgato, (unknown), Roberto Bernardoni, Murray D. Norris, Michelle Haber, Giorgio Milazzo, Giovanni Perini	5
9	MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma 2018 ·Oncotarget ·Saurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, Ronald J. Bernardi, Zaowen Chen, (unknown), Jan Köster, Giovanni Perini, Cristian Coarfa, Jason M. Shohet	28
10	Aerobic Growth of Rhodococcus aetherivorans BCP1 Using Selected Naphthenic Acids as the Sole Carbon and Energy Sources 2018 ·Frontiers in Microbiology ·Alessandro Presentato, Martina Cappelletti, Anna Sansone, Carla Ferreri, Elena Piacenza, Marc Demeter, Silvia Crognale, Maurizio Petruccioli, Giorgio Milazzo, Stefano Fedi, Alexander Steinbüchel, Raymond J. Turner, Davide Zannoni	37
11	The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription 2017 ·Cancer Research ·Matthew Wong, Andrew E. Tee, Giorgio Milazzo, Jessica L. Bell, Rebecca C. Poulos, Bernard Atmadibrata, Yuting Sun, Duohui Jing, Nicholas Ho, Dora Ling, (unknown), Xu Dong Zhang, Stefan Hüttelmaier, Jason W.H. Wong, Jenny Wang, Patsie Polly, Giovanni Perini, Christopher J. Scarlett, Tao Liu	53
12	Abstract 2450: MYCN and TFAP4 promote neuroblastoma malignancy by cooperating in the regulation a subset of target genes involved in cancer cell growth and metastasis 2016 ·Cancer Research ·Chengyuan Xue, Denise Yu, Samuele Gherardi, Jessica Koach, Giorgio Milazzo, Laura D. Gamble, Bing Liu, Amanda J. Russell, Tao Liu, Belamy B. Cheung, Glenn M. Marshall, Giovanni Perini, Michelle Haber, Murray D. Norris	2
13	Abstract 2664: Eradication of neuroblastoma by suppressing the expression of a single long noncoding RNA 2016 ·Cancer Research ·Andrew E. Tee, Pei Y. Liu, Giorgio Milazzo, Jo Vandesompele, Glenn M. Marshall, Giovanni Perini, Pieter Mestdagh, Marcel E. Dinger, Tao Liu	1
14	MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4 2016 ·Oncotarget ·Chengyuan Xue, Denise Yu, Samuele Gherardi, Jessica Koach, Giorgio Milazzo, Laura D. Gamble, Bing Liu, Emanuele Valli, Amanda J. Russell, Wendy B. London, Tao Liu, Belamy B. Cheung, Glenn M. Marshall, Giovanni Perini, Michelle Haber, Murray D. Norris	18
15	Proffered Paper: Targeting PA2G4, a novel MYCN co-factor, for the treatment of neuroblastoma 2016 ·European Journal of Cancer ·Jessica Koach, Jayne Murray, Joshua A. McCarroll, Giorgio Milazzo, Giovanni Perini, Michelle Haber, Murray D. Norris, Jamie I. Fletcher, Belamy B. Cheung, (unknown)	1
16	Growth of Rhodococcus sp. strain BCP1 on gaseous n-alkanes: new metabolic insights and transcriptional analysis of two soluble di-iron monooxygenase genes breakdown → 2015 ·Frontiers in Microbiology ·Martina Cappelletti, Alessandro Presentato, Giorgio Milazzo, Raymond J. Turner, Stefano Fedi, Dario Frascari, Davide Zannoni	1591
17	SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma 2015 ·Cancer Letters ·(unknown), (unknown), Giorgio Milazzo, Samuele Gherardi, Giovanni Perini, Elaine Willmore, David R. Newell, Deborah A. Tweddle	20
18	Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma 2015 ·Oncotarget ·Stefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, Susanna Ambrosio, (unknown), Luigi Lania, Giovanni Perini, Barbara Majello	43
19	Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression 2014 ·JNCI Journal of the National Cancer Institute ·Pei Y. Liu, (unknown), Glenn M. Marshall, Andrew E. Tee, Patsie Polly, Matthew Wong, Bing Liu, Jessica L. Bell, Xu Dong Zhang, Giorgio Milazzo, Belamy B. Cheung, Archa H. Fox, Alexander Swarbrick, Stefan Hüttelmaier, Maria Kavallaris, Giovanni Perini, John S. Mattick, Marcel E. Dinger, Tao Liu	89
20	Effect of Various Stimulants and Inhibitors of Gastric Acid Secretion on Mucosal Potential Difference in Man 1980 ·Scandinavian Journal of Gastroenterology ·Fabio Baldi, M. Salera, F Ferrarini, Giorgio Milazzo, M. Miglioli, Barbara Leggett	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact